XtalPi files FDA application for intestinal pain drug candidate
September 28, 2026 | 14:20
Technology firm XtalPi submitted an Investigational New Drug application to the US Food and Drug Administration to initiate clinical trials for its gut-restricted inhibitor KQTD-126.
Mobile Version